phenyl butyrate

Phenyl butyrate is a non-selective ERS inhibitor that attenuates angiotensin II-induced abdominal aortic aneurysm.

Sodium 4-phenylbutyrate (TriButyrate), a transcriptional regulator, reversibly inhibits class I and II histone deacetylases (HDACs )resulting in a global increase in gene expression, decreased cellular proliferation, increased cell differentiation, and the induction of apoptosis in susceptible tumor cell populations.

Glycerol phenylbutyrate (HPN-100) (GPB) is a new generation ammonia scavenger drug and it also is a sigma-2 (σ2) receptor ligand (pKi: 8.02).

Phenylbutyrate-d11(sodium) is the deuterated form of Sodium 4-phenylbutyrate. Sodium 4-phenylbutyrate (4-PBA sodium) acts as an inhibitor of histone deacetylase (HDAC) and endoplasmic reticulum stress (ERS), and is utilized in research related to diseases such as cancer and infections.

4-Nitrophenyl butyrate is composed of a butyric acid chain esterified with a 4-nitrophenol group, giving it a yellow appearance. This compound is commonly used as a substrate in enzyme assays to measure the activity of esterases and lipases. When these enzymes cleave the ester bond, the nitrophenol group is released, changing the color from yellow to orange. The rate of this color change can be used to determine enzyme activity. Additionally, 4-Nitrophenyl butyrate serves as a reagent in organic synthesis and as an intermediate in dye production.

Glycerol phenylbutyrate-D15 is a deuterium-labeled Glycerol phenylbutyrate. Glycerol phenylbutyrate is a sigma-2 (σ2) receptor ligand (pKi: 8.02).

Glycerol phenylbutyrate-D5 is a deuterium-labeled Glycerol phenylbutyrate. Glycerol phenylbutyrate is a sigma-2 (σ2) receptor ligand (pKi: 8.02).